Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03749187
Title BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas (PNOC017)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors University of California, San Francisco
Indications

glioblastoma

high grade glioma

Therapies

Pamiparib + Temozolomide

Age Groups: adult | child
Covered Countries USA

Additional content available in CKB BOOST